Much of the controversy over the causes of electrohypersensitivity (EHS) and multiple chemical sensitivity (MCS) lies in the absence of both recognized clinical criteria and objective biomarkers for widely accepted diagnosis.
Reliable disease biomarkers characterizing andidentifying electrohypersensitivity and multiplechemical sensitivity as two etiopathogenicaspects of a unique pathological disorder
